Paediatric Subjects - Special Survey

Novo Nordisk

Status: Completed

Conditions: Diabetes Mellitus, Type 1; Diabetes; Diabetes Mellitus, Type 2

Treatments: Drug: insulin aspart

Study type: Observational

Funder types: Industry

Identifiers

NCT01538576

BIASP-1942

Details and patient eligibility

About

This study is conducted in Japan. The aim of this study is to collect safety and efficacy data when using insulin aspart in children with diabetes under normal clinical practice conditions.

Enrollment: 71 patients

Sex: All

Ages: Under 15 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Subjects with diabetes requiring insulin therapy

Exclusion criteria

• Subjects who had treatment history of insulin aspart

Trial design

71 participants in 1 patient group

Insulin aspart users

Treatment:

Drug: insulin aspart